Early Notification and Brand Change Atomoxetine
Further to our original Early Notification and Brand Change dated 31 January 2019 and subsequent notifications of 17 June 2019 and 17 October 2019, we wish to provide this update which has been notified by PHARMAC via the Pharmaceutical Schedule Update for January 2020.
Listing of Atomoxetine Generic Partners is further delayed until 1 April 2020.
As advised via PHARMAC proposal of 10 December 2018 and the notification of the PHARMAC decision of 31 January 2019 there is to be a change in the listing and future sole supply of Atomoxetine.
New listing from 1 April 2020
Atomoxetine Cap 10 mg 28 Pharmacode TBA Schedule price $18.41
Atomoxetine Cap 18 mg 28 Pharmacode TBA Schedule price $27.06
Atomoxetine Cap 28 mg 28 Pharmacode TBA Schedule price $29.22
Atomoxetine Cap 40 mg 28 Pharmacode TBA Schedule price $29.22
Atomoxetine Cap 60 mg 28 Pharmacode TBA Schedule price $46.51
Atomoxetine Cap 80 mg 28 Pharmacode TBA Schedule price $56.45
Atomoxetine Cap 100 mg 28 Pharmacode TBA Schedule price $58.48
Incumbent brand
Strattera Cap 10 mg 28 Pharmacode 2181568 Schedule price $107.03
Strattera Cap 18 mg 28 Pharmacode 2181576 Schedule price $107.03
Strattera Cap 25mg 28 Pharmacode 2181584 Schedule price $107.03
Strattera Cap 40 mg 28 Pharmacode 2181592 Schedule price $107.03
Strattera Cap 60 mg 28 Pharmacode 2181541 Schedule price $107.03
Strattera Cap 80 mg 28 Pharmacode 2319551 Schedule price $139.11
Strattera Cap 100 mg 28 Pharmacode 2319578 Schedule price $139.11
Reference pricing will apply from 1 June 2020.
HSS (Hospital Supply Status) commences 1 June 2020.
CSS (Community Supply Status) commences 1 September 2020.
Brand switch fee to apply from 1 September 2020 to 30 November 2020.
As of the date of this notification ProPharma / PWR cannot accept Strattera Capsule for credit under any circumstances.
We would recommend you continue to purchase the incumbent and we will change automatically as existing stocks are exhausted. But be very wary of holding stock.
Benefit of staying with incumbent until 31 May 2020
10 mg : – Dispensing is 28 capsules. Therefore 1 x 28 @ $107.03 x 3% = $3.2109 plus $0.255 (pack fee) giving you $3.4659
Compared to $18.41 x 3% = $0.5523 plus $0.253 (pack fee) giving you $0.8053
18 mg : – Dispensing is 28 capsules. Therefore 1 x 28 @ $107.03 x 3% = $3.2109 plus $0.255 (pack fee) giving you $3.4659
Compared to $27.06 x 3% = $0.8118 plus $0.253 (pack fee) giving you $1.0648
25 mg : – Dispensing is 28 capsules. Therefore 1 x 28 @ $107.03 x 3% = $3.2109 plus $0.255 (pack fee) giving you $3.4659
Compared to $29.22 x 3% = $0.8766 plus $0.253 (pack fee) giving you $1.1296
40 mg : – Dispensing is 28 capsules. Therefore 1 x 28 @ $107.03 x 3% = $3.2109 plus $0.255 (pack fee) giving you $3.4659
Compared to $29.22 x 3% = $0.8766 plus $0.253 (pack fee) giving you $1.1296
60 mg : – Dispensing is 28 capsules. Therefore 1 x 28 @ $107.03 x 3% = $3.2109 plus $0.255 (pack fee) giving you $3.4659
Compared to $46.51 x 3% = $1.3953 plus $0.253 (pack fee) giving you $1.6483
80 mg : – Dispensing is 28 capsules. Therefore 1 x 28 @ $139.11 x 3% = $4.1733 plus $0.255 (pack fee) giving you $4.4283
Compared to $56.45 x 3% = $1.6935 plus $0.253 (pack fee) giving you $1.9465
100 mg : – Dispensing is 28 capsules. Therefore 1 x 28 @ $139.11 x 3% = $4.1733 plus $0.255 (pack fee) giving you $4.4283
Compared to $58.48 x 3% = $1.7544 plus $0.253 (pack fee) giving you $2.0074
You MUST manage your stock so that you have ZERO stock at time of reference pricing 1 June 2020. Failure to do so could prove very costly.
Once again we need your support to ensure stock in the supply chain moves through, to effectively ensure no losses are incurred.
Together we can make this a seamless and painless transition.
We thank you in anticipation of your ongoing support.
